Back
Harvard Bioscience, Inc. 10K Form
Buy
55
HBIO
Harvard Bioscience, Inc.
Last Price:
$0.73
Seasonality Move:
0.41%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
| 2023-11-07 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
| 2023-08-08 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
| 2023-04-26 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
| 2022-11-09 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
| 2022-08-04 | 10Q | HBIO/Harvard Bioscience, Inc. Quarterly |
Receive HBIO News And Ratings
See the #1 stock for the next 7 days that we like better than HBIO
HBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $94.1M |
|---|---|
| Cash Flow: | $482K |
| Price / Cash Flow: | 5.23 |
| Annual Sales: | $0.32 |
| Price / Book: | 2.29 |
Profitability
| EPS (TTM): | -1.22030 |
|---|---|
| Net Income (TTM): | $-53.8M |
| Gross Margin: | $49.6M |
| Return on Equity: | -155.33% |
| Return on Assets: | -54.29% |
Harvard Bioscience, Inc. Earnings Forecast
Key Harvard Bioscience, Inc. Financial Ratios
-
The Gross Profit Margin over the past 27 years for HBIO is 52.64%.
-
The Selling, General & Administrative Expenses for HBIO have been equal to 46.43% of Gross Profit Margin.
-
The Research & Development expenses have been 11.05% of Revenue.
-
The Net Earning history of HBIO is -13.18% of Total Revenues.
-
Per Share Earnings over the last 27 years have been positive in 13 years.
Harvard Bioscience, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | HBIO |
| CUSIP: | 416906 |
| Website: | harvardbioscience.com |
Debt
| Debt-to-Equity Ratio: | 3.04 |
|---|---|
| Current Ratio: | 0.81 |
| Quick Ratio: | 0.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 7.61 |
HBIO Technical Analysis vs Fundamental Analysis
Buy
55
Harvard Bioscience, Inc. (HBIO)
is a Buy
Is Harvard Bioscience, Inc. a Buy or a Sell?
-
Harvard Bioscience, Inc. stock is rated a BuyThe current Harvard Bioscience, Inc. [HBIO] share price is $0.72. The Score for HBIO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.